Private markets firm HarbourVest sees investment opportunities in Asia including China's healthcare services and consumer industries, with the country's declining demographics and uptick in retail spending lifting demand for related products. Trends like the reshuffling of global supply chains in the year ahead will also throw up opportunities in Japan and South Korea in high-end manufacturing, while regions like India and Southeast Asia will benefit in more labour-intensive industries like textiles. "We think that Asia will see very good growth in 2024, and that growth is very much underpinned by China," said Kelvin Yap, managing director at HarbourVest, a global private markets firm with over US$117 billion in assets under management. China, Asia's single largest economy, will grow at around 5 per cent, "a very high number," he added. Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team. Healthcare services will be a main area of focus for HarbourVest's China investments this year, as the country's ageing population and growing household income drive demand for "more premium and better healthcare services", including outpatient treatment and elective surgeries. An elderly man is being escorted by medical staff during rehabilitation training at a rehabilitation sports function room of the Wuyang Street Community Health Service Center in Deqing County, Huzhou, China. Photo: Getty Images alt=An elderly man is being escorted by medical staff during rehabilitation training at a rehabilitation sports function room of the Wuyang Street Community Health Service Center in Deqing County, Huzhou, China. Photo: Getty Images> Consumption will be another key investment theme for the firm, despite muted confidence and a slow rebound in spending in recent years. "I know consumption has not exactly bounced back, but if you look at big-ticket items such as motor vehicles, sales are actually at an all-time high, suggesting that there is still buying power," said Yap. He also pointed out that a trend towards "consumption downgrades", where pessimism about the country's economic outlook is making consumers adopt a more frugal lifestyle, will be more than compensated for by an uptick in volume, which will in turn drive up the total value of consumption. "So for any products that tend to be more [mass-oriented], there is a good value proposition, and where their price is a fraction of a much better product, we see opportunities - [even if] they might not enjoy the same brand recognition," he said. Another key factor that makes China's consumption and healthcare services attractive is that these sectors are less susceptible to regulatory scrutiny, compared to the more sensitive areas like hard tech and semiconductors, which the firm tries to stay away from, Yap said. HarbourVest's China portfolio consists of investments in local private equity and venture capital funds, as well as direct investments in Chinese companies alongside local fund managers. Elsewhere in Asia, a trend towards supply chain diversification, where companies seek to shift manufacturing and investments out of China and into other promising geographies as a hedge against geopolitical risks, is driving opportunities in the region's logistics companies. "Supply chains are being unwound and re-engineered," he said. "What that means is that you're going to have a lot more disparate supply chain. There's going to be a lot more logistics involved in moving, assembling and shipping intermediate and finished goods. As companies are rejigging their supply chains, there will be a lot more demand for logistics services." India and Southeast Asia will emerge as winners as a result of this shift, outperforming at the lower-end of the value chain and in more labour-intensive industries such as textiles, while countries like Japan and South Korea will take the lead in high-end manufacturing, he said. What that means for Chinese companies is that to stay competitive, they can either stay in China and move up the value chain, or diversify into other markets while retaining industry focus, said Yap. "Since supply chain shifts do not happen overnight, we're also likely going to see a combination of both strategies among Chinese companies." This article originally appeared in the South China Morning Post (SCMP), the most authoritative voice reporting on China and Asia for more than a century. For more SCMP stories, please explore the SCMP app or visit the SCMP's Facebook and Twitter pages. Copyright © 2024 South China Morning Post Publishers Ltd. All rights reserved. Copyright (c) 2024. South China Morning Post Publishers Ltd. All rights reserved.
China to drive private market opportunities in Asia as healthcare, consumption offer pickings: HarbourVest
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...